dc.contributor.author
Ordulu, Zehra
dc.contributor.author
Chai, Hongyan
dc.contributor.author
Peng, Gang
dc.contributor.author
McDonald, Anna G..
dc.contributor.author
De Nictolis, Michele
dc.contributor.author
Garcia-Fernandez, Eugenia
dc.contributor.author
Hardisson, David
dc.contributor.author
Prat, Jaime
dc.contributor.author
Li, Peining
dc.contributor.author
Hui, Pei
dc.contributor.author
Oliva, Esther
dc.contributor.author
Buza, Natalia
dc.identifier
https://ddd.uab.cat/record/233520
dc.identifier
urn:10.1038/s41379-020-0546-8
dc.identifier
urn:oai:ddd.uab.cat:233520
dc.identifier
urn:pmcid:PMC7483566
dc.identifier
urn:pmc-uid:7483566
dc.identifier
urn:pmid:32341498
dc.identifier
urn:articleid:15300285v33p1844
dc.identifier
urn:oai:pubmedcentral.nih.gov:7483566
dc.description.abstract
Intravenous leiomyomatosis (IVL) is an unusual uterine smooth muscle proliferation that can be associated with aggressive clinical behavior despite a histologically benign appearance. It has some overlapping molecular characteristics with both uterine leiomyoma and leiomyosarcoma based on limited genetic data. In this study, we assessed the clinical and morphological characteristics of 28 IVL and their correlation with molecular features and protein expression, using array comparative genomic hybridization (aCGH) and Cyclin D1, p16, phosphorylated-Rb, SMARCB1, SOX10, CAIX, SDHB and FH immunohistochemistry. The most common morphologies were cellular (n=15), usual (n=11) and vascular (n=5; including 3 cellular IVL showing both vascular and cellular features). Among the immunohistochemical findings, the most striking was that all IVL showed differential expression of either p16 or Cyclin D1 in comparison to surrounding non-neoplastic tissue. Cytoplasmic phosphorylated-Rb was present in all but one IVL with hyalinization. SMARCB1, FH and SDHB were retained; S0X10 and CAIX were not expressed. The most common genetic alterations involved 1p (39%), 22q (36%), 2q (29%), 1q (25%), 13q (21%) and 14q (21%). Hierarchical clustering analysis of recurrent aberrations revealed 3 molecular groups: Group 1 (29%) and 2 (18%) with associated del(22q) and group 3 (18%) with del(10q). The remaining IVL had non-specific or no alterations by aCGH. Genomic index scores were calculated for all cases and showed no significant difference between the 14 IVL associated with aggressive clinical behavior (extrauterine extension or recurrence) and those without (median scores 5.15 vs 3.5). Among the 5 IVL associated with recurrence, 4 had a vascular morphology and 3 had alterations of 8q. Recurrent chromosome alterations detected herein overlap with those observed in the spectrum of uterine smooth muscle tumors and involve genes implicated in mesenchymal tumors at different sites with distinct morphological features.
dc.format
application/pdf
dc.relation
Modern Pathology ; Vol. 33 (april 2020), p. 1844-1860
dc.rights
Aquest material està protegit per drets d'autor i/o drets afins. Podeu utilitzar aquest material en funció del que permet la legislació de drets d'autor i drets afins d'aplicació al vostre cas. Per a d'altres usos heu d'obtenir permís del(s) titular(s) de drets.
dc.rights
https://rightsstatements.org/vocab/InC/1.0/
dc.subject
Intravenous leiomyomatosis
dc.subject
Angioleiomyoma
dc.subject
Phosphorylated Rb
dc.title
Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis